explore -WSS

explore

author：entertainment 2025-10-01 10:59:39 - browse：2

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

Scientists at the Food and Drug Administration have two big questions about Eli Lilly’s experimental Alzheimer’s drug donanemab ahead of a panel of outside experts that it is convening on Monday:

Should the patients who receive the medicine be limited based on PET scans of a protein called tau that Eli Lilly used as a key criteria for trying to determine whether they should receive the drug? That could reduce usage of the medicine by adding a barrier to its use.

And how do the potential risks of using the drug compare to its benefits? The FDA points to one analysis, admittedly with missing data, that could indicate patients who receive the drug have a higher risk of dying.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

focus

WSS

How to protect coverage of PrEP

Weekend shootings leave at least 6 dead, 20 others wounded in Chicago

Empower primary care with adequate payments and technology

Crowdfunding for medical bills sidesteps core problem, author says

Black vets could get higher VA benefits if race not used in lung test

Empower primary care with adequate payments and technology

focus

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Wikipedia

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Severe heat forecast: Where scorching temperatures will persist over the next week

Alkermes shareholders re

Has Bernie Sanders reached the limit of his pharma bullying effort?

BioMarin wins approval for gene therapy to treat hemophilia A

Severe heat forecast: Where scorching temperatures will persist over the next week

Walensky prepares to leave CDC — and Congress — behind

Thousands protest mob assault of women who were paraded naked in remote Indian border state

Jerome Adams on the need for new antivirals for Covid

Thousands protest mob assault of women who were paraded naked in remote Indian border state

explore

Class action alleges UnitedHealth concealed DOJ probe

Novel spinal cord stimulator treats paralysis without surgery

Novartis develops a rapidly manufactured CAR

Burning questions about Delta and the next phase of the Covid pandemic

PrEP can help anyone prevent HIV. Why do so few people take it?

Primary care doctor shortage won't be solved by free med school tuition

knowledge

hotspot

focus

knowledge